相关实验视频

Updated: Jul 18, 2026

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

A Semi-Quantitative Drug Affinity Responsive Target Stability DARTS assay for studying Rapamycin/mTOR interaction

Published on: August 27, 2019

D-DARTS:一种基于双药亲和反应目标稳定性的NaV1.5亲和分子识别的替代方法

Zirui Lü¹, Xiandong Dai¹, Huixia Li¹

¹State Key Laboratory of Chemistry for NBC Hazards Protection, Beijing 102205, China.

Bioorganic & medicinal chemistry

|October 14, 2025

概括

双DARTS (D-DARTS) 是一种通过评估对化学和酶降解的双稳定性来识别蛋白质结合物的新方法. 这种技术成功地识别了NaV1.5通道的配体,包括子弹的质 poneratoxin.

科学领域:

生物化学生化学
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

药物亲和度响应目标稳定性 (DARTS) 是一种检测目标参与的无标签方法.
由于它们的不稳定性和蛋白质酶抵抗性,DARTS对多跨膜通道蛋白的应用是有限的.

研究的目的:

开发一种新的策略,双DARTS (D-DARTS),用于评估针对化学变性和酶降解的目标蛋白的稳定性.
为了确定NaV1.5通道的亲缘关系联体,并评估D-DARTS对多晶膜蛋白的一般实用性.

主要方法:

在含有SDS的变质缓冲器中使用受控蛋白质分解开发的双DARTS (D-DARTS).
应用了D-DARTS来识别NaV1.5通道结合物和线粒体蛋白VDAC1.1.
使用电生理学测定和分子对接验证的结果.

主要成果:

通过使用D-DARTS成功识别了NaV1.5通道的抑制剂和激动剂.
发现 poneratoxin 是一种高亲和度的 NaV1.5 结合剂,具有结合部位预测.
证明了D-DARTS对VDAC1的适用性,证实了它的广泛实用性.

结论:

通过D-DARTS,可以对具有挑战性的多跨膜蛋白进行目标参与评估.
这种方法为选通道蛋白质结合物的电生理学提供了一个简单,具有成本效益的替代方案.
D-DARTS是一种有前途的策略,用于在各种跨膜蛋白中进行目标识别和活性分子选.

关键词:

这些都是D-DARTS.的 NaV1.5 频道.蛋白酶K是一种蛋白酶.VDAC1,目标识别目标识别双药 afinity 响应性目标稳定性目标稳定性

更多相关视频

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

相关概念视频

Drug-Receptor Bonds

Drug-Receptor Bonds

Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...